Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Glenmark Pharmaceuticals Inc. USA launches Latanoprost Ophthalmic Solution".
Glenmark Pharmaceuticals Limited Press Release Feb 14 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
In the deck
Earlier from Glenmark Pharmaceuticals
- Press Release Feb 12 2025
- Press Release Feb 10 2025
- Press Release Jan 21 2025
- Press Release Dec 16 2024
- Press Release Dec 10 2024
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Feb 27 2025
- Glenmark Pharmaceuticals Limited Press Release Mar 03 2025
- Glenmark Pharmaceuticals Limited Press Release Mar 10 2025
- Press Release Mar 12 2025
- Press Release Mar 20 2025
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals